WO2014052519A1 - Methods for treating wellbore and wellbore operation fluids - Google Patents
Methods for treating wellbore and wellbore operation fluids Download PDFInfo
- Publication number
- WO2014052519A1 WO2014052519A1 PCT/US2013/061804 US2013061804W WO2014052519A1 WO 2014052519 A1 WO2014052519 A1 WO 2014052519A1 US 2013061804 W US2013061804 W US 2013061804W WO 2014052519 A1 WO2014052519 A1 WO 2014052519A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bacteriocins
- treatment fluid
- combination
- wellbore
- wellbore treatment
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 146
- 238000000034 method Methods 0.000 title claims abstract description 40
- 108010062877 Bacteriocins Proteins 0.000 claims abstract description 93
- 238000011282 treatment Methods 0.000 claims abstract description 92
- 230000001580 bacterial effect Effects 0.000 claims abstract description 66
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 58
- 241000894006 Bacteria Species 0.000 claims abstract description 32
- -1 poly(lactide) Polymers 0.000 claims description 45
- 238000000576 coating method Methods 0.000 claims description 20
- 239000011248 coating agent Substances 0.000 claims description 19
- 239000002738 chelating agent Substances 0.000 claims description 11
- 241000192125 Firmicutes Species 0.000 claims description 9
- IEBXZRQOXHLIGF-UHFFFAOYSA-N 5,5-dimethyl-4-(2-methylprop-1-enyl)oxolan-2-one Chemical compound CC(C)=CC1CC(=O)OC1(C)C IEBXZRQOXHLIGF-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 229920003232 aliphatic polyester Polymers 0.000 claims description 7
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 claims description 6
- 229920001710 Polyorthoester Polymers 0.000 claims description 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- CTBBEXWJRAPJIZ-VHPBLNRZSA-N (1S,2S,3S,6R,8R,9S,10R)-2-benzoyl-1,3,8,10-tetrahydroxy-9-(4-methoxy-6-oxopyran-2-yl)-5-oxatricyclo[4.3.1.03,8]decan-4-one Chemical compound O1C(=O)C=C(OC)C=C1[C@H]1[C@]([C@@H]2O)(O)[C@H](C(=O)C=3C=CC=CC=3)[C@@]3(O)C(=O)O[C@@H]2C[C@]31O CTBBEXWJRAPJIZ-VHPBLNRZSA-N 0.000 claims description 5
- 229920002101 Chitin Polymers 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 5
- CTBBEXWJRAPJIZ-UHFFFAOYSA-N Enterocin Natural products O1C(=O)C=C(OC)C=C1C1C(C2O)(O)C(C(=O)C=3C=CC=CC=3)C3(O)C(=O)OC2CC31O CTBBEXWJRAPJIZ-UHFFFAOYSA-N 0.000 claims description 5
- 108010053775 Nisin Proteins 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 5
- 229940065514 poly(lactide) Drugs 0.000 claims description 5
- 239000002745 poly(ortho ester) Substances 0.000 claims description 5
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 5
- 229920000515 polycarbonate Polymers 0.000 claims description 5
- 239000004417 polycarbonate Substances 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 4
- 108010073254 Colicins Proteins 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- GDSYPXWUHMRTHT-UHFFFAOYSA-N Epidermin Natural products N#CCC(C)(C)OC1OC(CO)C(O)C(O)C1O GDSYPXWUHMRTHT-UHFFFAOYSA-N 0.000 claims description 4
- 108090000988 Lysostaphin Proteins 0.000 claims description 4
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims description 4
- 108010080032 Pediocins Proteins 0.000 claims description 4
- 108010056995 Perforin Proteins 0.000 claims description 4
- 102000004503 Perforin Human genes 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 4
- 102000002262 Thromboplastin Human genes 0.000 claims description 4
- 108010000499 Thromboplastin Proteins 0.000 claims description 4
- 239000002280 amphoteric surfactant Substances 0.000 claims description 4
- 239000003945 anionic surfactant Substances 0.000 claims description 4
- LOHQECMUTAPWAC-UHFFFAOYSA-N coagulin Natural products C1C(C)=C(CO)C(=O)OC1C1(C)C(C2(C)CCC3C4(C(=O)CC=CC4=CCC43)C)(O)CCC24O1 LOHQECMUTAPWAC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 108010064962 epidermin Proteins 0.000 claims description 4
- CXTXHTVXPMOOSW-JUEJINBGSA-N epidermin Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@H](C(N\C=C/SC2)=O)CSC1)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 CXTXHTVXPMOOSW-JUEJINBGSA-N 0.000 claims description 4
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 108010047651 gallidermin Proteins 0.000 claims description 4
- AHMZTHYNOXWCBS-PCUVAHMGSA-N gallidermin Chemical compound C([C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C\C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](C(N/C=C/SC2)=O)CSC1)=O)=O)C1=CC=CC=C1 AHMZTHYNOXWCBS-PCUVAHMGSA-N 0.000 claims description 4
- 108010070411 gardimycin Proteins 0.000 claims description 4
- LAWKVNVCUPIOMG-HWWYPGLISA-N gardimycin Chemical compound C1=CC=C2C(C[C@H](C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CC)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(O)=O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CC)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)N)[C@@H](C)CC)C(C)C)=CNC2=C1 LAWKVNVCUPIOMG-HWWYPGLISA-N 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- 239000002563 ionic surfactant Substances 0.000 claims description 4
- SRCAXTIBNLIRHU-JJKPAIEPSA-N lantibiotic pep5 Chemical compound N([C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N\C(=C/C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N\C(=C(/C)S)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)C(=O)CC SRCAXTIBNLIRHU-JJKPAIEPSA-N 0.000 claims description 4
- NTIBMIIYTKPBNR-UHFFFAOYSA-N methoxymethyl 2-hydroxybenzoate Chemical compound COCOC(=O)C1=CC=CC=C1O NTIBMIIYTKPBNR-UHFFFAOYSA-N 0.000 claims description 4
- 108010012906 microbisporicin Proteins 0.000 claims description 4
- 108010079904 microcin Proteins 0.000 claims description 4
- 108010086913 mundticin Proteins 0.000 claims description 4
- SUJOIPVTNUVDCB-UHFFFAOYSA-N mutactin Natural products CC1=CC(O)=C2C(=O)CC(O)CC2=C1C1=CC(O)=CC(=O)O1 SUJOIPVTNUVDCB-UHFFFAOYSA-N 0.000 claims description 4
- 239000004309 nisin Substances 0.000 claims description 4
- 235000010297 nisin Nutrition 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 4
- 108010037687 staphylococcin Proteins 0.000 claims description 4
- 101150099695 vps11 gene Proteins 0.000 claims description 4
- MJOQJPYNENPSSS-XQHKEYJVSA-N [(3r,4s,5r,6s)-4,5,6-triacetyloxyoxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CO[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O MJOQJPYNENPSSS-XQHKEYJVSA-N 0.000 claims description 3
- 108010049145 capistruin Proteins 0.000 claims description 3
- 108010067071 duramycin Proteins 0.000 claims description 3
- SFWLDKQAUHFCBS-WWXQEMPQSA-N lancovutide Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@@H](CCCCNC[C@H]4C(=O)N[C@@H](CC=5C=CC=CC=5)C(=O)NCC(=O)N5CCC[C@H]5C(=O)N[C@@H](CC=5C=CC=CC=5)C(=O)N[C@H]([C@@H](SC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSC3C)CSC2)C(=O)N4)C)C(=O)N1)C(O)=O)[C@@H](O)C(O)=O)=O)C(C)C)C1=CC=CC=C1 SFWLDKQAUHFCBS-WWXQEMPQSA-N 0.000 claims description 3
- 239000000356 contaminant Substances 0.000 description 11
- 239000003139 biocide Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 4
- 239000003899 bactericide agent Substances 0.000 description 4
- 229920006237 degradable polymer Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 231100001261 hazardous Toxicity 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000206594 Carnobacterium Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920005576 aliphatic polyanhydride Polymers 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- ATZQZZAXOPPAAQ-UHFFFAOYSA-M caesium formate Chemical compound [Cs+].[O-]C=O ATZQZZAXOPPAAQ-UHFFFAOYSA-M 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- NMJORVOYSJLJGU-UHFFFAOYSA-N methane clathrate Chemical compound C.C.C.C.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O NMJORVOYSJLJGU-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002455 scale inhibitor Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/02—Well-drilling compositions
- C09K8/03—Specific additives for general use in well-drilling compositions
- C09K8/035—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K8/00—Compositions for drilling of boreholes or wells; Compositions for treating boreholes or wells, e.g. for completion or for remedial operations
- C09K8/60—Compositions for stimulating production by acting on the underground formation
- C09K8/605—Compositions for stimulating production by acting on the underground formation containing biocides
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
- E21B37/00—Methods or apparatus for cleaning boreholes or wells
- E21B37/06—Methods or apparatus for cleaning boreholes or wells using chemical means for preventing or limiting, e.g. eliminating, the deposition of paraffins or like substances
Definitions
- the present invention relates to methods for combati ng biological contamination in a wellbore or surrou nding subterranean formation and in wellbore operation flu ids using bacteriocins.
- Oil well stimulation, drilling, recovery, and cleanup operations are often negatively affected by the presence of bacterial contaminants. These contaminants may be present in the liquid treatment fluids or equipment (e.g. , tanks, pumps, structural members, etc.) used for well operations, the subterranean formation itself, or flowback fluids. Bacterial contaminants may cause numerous problems, such as increased corrosion rates and plugging of condu its, filters, and pumps, reservoir sou ring, etc. They may additionally interfere with the desired operational qualities of a particu lar liquid treatment fluid or additive within the treatment fluid . Some bacteria release enzymes that degrade polymers commonly used in well operations and interfere with those operations.
- a number of methods have been used for reducing or eliminating bacterial contaminants in well operations, such as introducing biocides downhole or using biocides to sterilize flowback flu ids.
- biocides pose significant risk to human health and the environment. Great care is required when handling biocides, necessitating appropriate protective clothing and hazardous disposal practices. Additionally, biocides may have severe and lasting impacts on water sou rces and ecosystems, which may be a particular problem should a well operation fail or the recovered liquids become uncontained .
- Bacterial contaminants have also been mitigated by irradiation of well operation treatment flu ids and flowback flu ids with ultraviolet light (“UV”) .
- UV ultraviolet light
- UV irradiation is safer to use than biocides for controlling bacterial contamination .
- UV irradiation requires special UV light sou rces at the well site and may not effectively kill bacterial contaminants.
- any contaminants in the wellbore itself still remain and may propagate in the treatment fluids after they are introduced.
- well operation equipment may house bacterial contaminants and introduce those contaminants into already irradiated treatment fluids. Therefore, a method of effectively inhibiting bacterial contaminants in well operations that is safe for human handling and the environment may be beneficial to one of ordinary skill in the art.
- the present invention relates to methods for combating biological contamination in a wellbore or surrounding subterranean formation and in wellbore operation fluids using bacteriocins.
- the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; combining the wellbore treatment fluid with a plurality of bacteriocins; placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
- the present invention provides a method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
- the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; providing particulates having a coating of bacteriocins thereon and a coating of degradable material atop of the coating of bacteriocins; wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester),
- the present invention relates to methods for combating biological contamination in a wellbore or surrounding subterranean formation using bacteriocins.
- the methods of the various embodiments of the present invention may combat biological contamination in a wellbore and flowback fluids, while reducing or eliminating reliance on hazardous biocides or less effective antibacterial treatments.
- the methods disclosed herein may be used in any type of hydrocarbon recovery operation where disinfecting a treatment fluid or formation face is desired, including, but not limited to, pipeline operations, well servicing operations, upstream exploration and production operations, downstream refining, processing, storage and transportation applications, and sterilization of flowback fluids.
- bacteriocin refers to a protein or peptide produced by a gram-positive or a gram-negative bacterium that is bactericidal and/or bacteriostatic against organisms related to the producer bacterium, but that does not act against the producer bacterium itself. Bacteriocins, thus, are naturally occurring antibacterial agents. Additionally, bacteriocins are generally produced by non-pathogenic bacteria naturally found in the human body. Therefore, they are prime candidates for medicinal and food-related applications and are safe for human consumption. Indeed, the bacteriocin nisin is listed as Generally Recognized as Safe by the U.S. Food and Drug Administration.
- the present invention relates to a novel use of bacteriocins in well operations. Not only are bacteriocins useful as an antibacterial agent, they are also generally categorized as food-grade, ensuring that any inadvertent exposure to the bacteriocins would not be hazardous to flora, fauna, or human life.
- the wellbore treatment fluids of the present invention may be any suitable treatment fluids capable of use in a well operation.
- Suitable treatment fluids may include, but are not limited to, aqueous-based fluids, aqueous-miscible fluids, water-in-oil emulsions, or oil-in-water emulsions.
- Suitable aqueous-based fluids may include fresh water, saltwater (e.g. , water containing one or more salts dissolved therein), brine (e.g. , saturated salt water), seawater, and any combination thereof.
- Suitable aqueous-miscible fluids may include, but not be limited to, alcohols, e.g., methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, and t-butanol; glycerins; glycols, e.g., polyglycols, propylene glycol, and ethylene glycol; polyglycol amines; polyols; any derivative thereof; any in combination with salts, e.g., sodium chloride, calcium chloride, calcium bromide, zinc bromide, potassium carbonate, sodium formate, potassium formate, cesium formate, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, ammonium chloride, ammonium bromide, sodium nitrate, potassium nitrate, ammonium nitrate, ammonium sulfate, calcium nitrate,
- Suitable water-in-oil emulsions also known as invert emulsions, may have an oil-to-water ratio from a lower limit of greater than about 50 : 50, 55 : 45, 60 :40, 65 : 35, 70 : 30, 75 : 25, or 80 : 20 to an upper limit of less than about 100 : 0, 95 : 5, 90 : 10, 85 : 15, 80 : 20, 75 : 25, 70 : 30, or 65 : 35 by volume in the base fluid, where the amount may range from any lower limit to any upper limit and encompass any subset therebetween.
- suitable invert emulsions include those disclosed in U.S.
- Patent Numbers 5,905,061, 5,977,031, 6,828,279, 7,534,745, 7,645,723, and 7,696, 131 each of which are incorporated in their entirety herein by reference. It should be noted that for water-in-oil and oil-in-water emulsions, any mixture of the above may be used including the water being and/or comprising an aqueous-miscible fluid.
- the wellbore treatment fluids of the present invention may additionally contain an additive or combination of additives including, but not limited to, a salt, a weighting agent, an inert solid, a fluid loss control agent, an emulsifier, a dispersion aid, a corrosion inhibitor, an emulsion thinner, an emulsion thickener, a viscosifying agent, a gelling agent, a surfactant, a particulate, a proppant, a gravel particulate, a lost circulation material, a foaming agent, a gas, a pH control additive, a breaker, a biocide, a crosslinker, a stabilizer, a chelating agent, a scale inhibitor, a gas hydrate inhibitor, a mutual solvent, an oxidizer, a reducer, a friction reducer, a clay stabilizing agent, and any combination thereof.
- additives including, but not limited to, a salt, a weighting agent, an inert solid, a fluid loss control agent
- the wellbore treatment fluids of the present invention may include drilling fluids, lost circulation fluids, stimulation fluids, sand control fluids, completion fluids, acidizing fluids, scale inhibiting fluids, water-blocking fluids, clay stabilizer fluids, fracturing fluids, frac-packing fluids, gravel packing fluids, wellbore strengthening fluids, acidizing fluids, and sag control fluids.
- the methods and compositions of the present invention may be used in full-scale fluids or as pills.
- a "pill” is a type of relatively small volume of specially prepared treatment fluid placed or circulated in the wellbore.
- the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; combining the wellbore treatment fluid with a plurality of bacteriocins; placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial cou nt; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial cou nt.
- gram-positive produced bacteriocins generally, but not always, serve as a bactericide to gram-positive bacteria and gram-negative produced bacteriocins generally serve as a bactericide to gram-negative bacteria .
- treatment flu id, wellbore conditions, and other well operation parameters gram-positive bacteriocins, gram-negative bacteriocins, or a combination of both may be used in accordance with the present invention to inhibit bacterial growth .
- Suitable gram-positive bacteriocins include, but are not limited to, acidocin ; actagardine; bovicin ; brochocin; butyrivibriocin ; carnobacteriocin; carnocin ; carnocyclin ; circularin; closticin ; coagulin; curvacin; curvaticin; cytolysin; divercin ; divergicin; du ramycin; enterocin; entianin ; epicidin; epidermin ; epilancin; ericin; gallidermin ; garvicin; gassericin; halodu racin; hiracin ; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin; mut
- Suitable gram-negative bacteriocins include, but are not limited to, capistru in; colicin; microcin ; pyrocin; serracin; and any combination thereof. Any gram-positive bacteriocin may be combined with any gram-negative bacteriocin to produce the desired effects for a particu lar well operation.
- the bacteriocin is present in the wellbore treatment fluid in an amount from about 0.1 g/ml to about 300 g/ml .
- the bacteriocin is present in the wellbore treatment flu id in an amou nt from about 0. 1 g/ml to about 100 g/ml .
- Bacterial contamination in a well operation may exist in the treatment fluids themselves or the well (e.g., the su bterranean formation) .
- the treatment fluids containing bacteriocins of the present invention may serve as a bactericide to both because the bacteriocins may be effective against any surface which the treatment fluid contacts.
- the bacteriocins may additionally be used to treat flowback fluids for bacterial contamination .
- the present invention provides a method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
- flowback fluid refers to any fluids that flow from a wellbore following treatment with a wellbore treatment fluid, either in preparation for a subsequent phase of treatment or in preparation for cleanup.
- Flowback fluids may be any wellbore treatment fluid disclosed herein, including any additive or additives included therein, that flow from the wellbore and to the surface. Additionally, flowback fluids may include produced water or other fluids from the formation, but do not include produced fluids that are obtained during well production (e.g. , hydrocarbons).
- bacteriocins are able to operate at extreme pH levels.
- enterocin may be stable at low pH levels (2.0-5.0) and carnobacterium may be stable at high pH levels (8.5-9.5).
- bacteriocins are also able to operate at extreme temperatures.
- bacteriocins produced by Lactobacillus plantarum are thermotolerant at 100°C for at least 90 minutes and 121°C for at least 20 minutes. (Parada et al., Brazilian Archives of Bio. & Tech. 50 : 521-542 (2007)).
- Bacteriocin activity may be enhanced by the use of a chelating agent and/or a surfactant in combination with the bacteriocin.
- the use of a chelating agent and/or a surfactant in combination with a bacteriocin can enhance the potency and range of the bacteriocin as a bactericide.
- Suitable chelating agents include, but are not limited to EDTA, CaEDTA, CaNa 2 EDTA, alkyldiamine tetraacetates, EGTA, citrate, and any combination thereof.
- the chelating agent is present in an amount from about 0.1 imM to about 30 imM of the wellbore treatment fluid or flowback fluid.
- the surfactants used in the present invention may be ionic or nonionic.
- Suitable ionic surfactants include, but are not limited to emulsifiers, fatty acids, quaternary compounds, anionic surfactants (e.g. , sodium dodecyl sulphate), amphoteric surfactants ⁇ e.g. , cocamidopropyl betaine), and any combination thereof.
- Suitable nonionic surfactants include, but are not limited to, polyoxyalkylphenols ⁇ e.g. , Triton X- 100), polyoxyalkylsorbitans ⁇ e.g. , Tweens), glycerides ⁇ e.g. , monolaurin and dioleates), and any combination thereof.
- one or more surfactants are present in the wellbore treatment fluids and/or flowback fluids of the present invention in an amount from about 0.01% to about 5.0%. In other embodiments, the surfactants are present from about 0.1% to about 1.0% of the wellbore treatment fluids and/or flowback fluids.
- the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; providing particulates having a coating of bacteriocins thereon and a coating of degradable material atop of the coating of bacteriocins; wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a
- the bacteriocins may be advantageously delivered to a desired location in a subterranean formation along with particulates (such as proppant or gravel).
- particulates such as proppant or gravel.
- Suitable degradable coatings include degradable polymers, waxes, and latexes. Degradable polymers suitable for use in the present invention are capable of undergoing an irreversible degradation down hole.
- degradable means that the degradable material, once degraded down hole, should not recrystallize or reconsolidate while down hole, e.g. , the degradable material should degrade in situ but should not recrystallize or reconsolidate in situ .
- degradation or “degradable” refer to both the two relatively extreme cases of hydrolytic degradation that the degradable material may undergo, i.e. , heterogeneous (or bulk erosion) and homogeneous (or surface erosion), and any stage of degradation in between these two. This degradation can be a result of a physical change, chemical process, or a thermal process.
- Suitable examples of degradable polymers include, but are not limited to, polysaccharides; cellulose; chitins; chitosans; proteins; aliphatic polyesters; poly(lactides); poly(glycolides); poly(s- caprolactones); poly(hydroxybutyrates); poly(anhydrides); aliphatic polycarbonates; poly(orthoesters); poly(amino acids); poly(ethylene oxides); poly(vindylidene chloride); and polyphosphazenes. Of these suitable polymers, aliphatic polyesters and polyanhydrides may be preferred. Additional detail regarding acceptable degradable polymers can be found in U.S. Patent No. 7,044,220, the entire disclosure of which is hereby incorporated by reference.
- the bacteriocins may be coated directly onto a solid fluid loss control agent used in a subterranean treatment fluid.
- a solid fluid loss control agent used in a subterranean treatment fluid.
- the methods of the present invention are able to place the bacteriocins directly at, for example, a fracture face, thus potentially stopping the influx of harmful bacteria before they reach producing zones.
- Any solid fluid loss control agent known in the art may be used to deliver the bacteriocins in these embodiments of the present invention.
- Some common fluid loss control agents include silica, mica, calcite, aliphatic polyester, polylactic acid, a poly(lactide), a poly(orthoester), a surfactant- based fluid loss control agent (such as those described in United States Patent No. 7,413,013, the entire disclosure of which is hereby incorporated by reference), carboxymethylcellulose, carboxyethylcellulose, and polyacrylates.
- a chelating agent and/or a surfactant may be combined with the bacteriocin before it is coated onto the particulate.
- Embodiments disclosed herein include:
- a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a weiibore treatment fluid having a first weiibore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the weiibore treatment fluid; combining the weiibore treatment fluid with a plurality of bacteriocins; placing the weiibore treatment fluid into a weiibore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first weiibore treatment fluid bacterial count to a second weiibore treatment fluid bacterial count.
- a method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
- Each of embodiments A and B may have one or more of the following additional elements in any combination :
- Element 1 wherein the bacteriocins are coated onto a plurality of particulates and wherein a coating of degradable material is placed atop of the coating of bacteriocins, wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a poly(amino acid), a poly(ethylene oxide), a poly(vinylidene chloride), a polyphosphazene, or a combination thereof; and wherein the degradable coating degrades after the step of placing the weiibore treatment fluid into a weiibore.
- the degradable coating degrades after the step of placing the
- Element 2 wherein the bacteriocins are gram-positive bacteria produced bacteriocins, gram-negative bacteria produced bacteriocins, or a combination thereof.
- Element 3 wherein the bacteriocins are gram-positive bacteria produced bacteriocins selected from the group consisting of: acidocin; actagardine; bovicin; brochocin; butyrivibriocin; carnobacteriocin; carnocin; carnocyclin; circularin; closticin; coagulin; curvacin; curvaticin; cytolysin; divercin; divergicin; duramycin; enterocin; entianin; epicidin; epidermin; epilancin; ericin; gallidermin; garvicin; gassericin; haloduracin; hiracin; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin;
- Element 4 wherein the bacteriocins are gram-negative bacteria produced bacteriocins selected from the group consisting of: capistruin; colicin; microcin; pyrocin; serracin; and any combination thereof.
- Element 5 wherein the bacteriocins are gram-positive bacteria produced bacteriocins and gram-negative bacteria produced bacteriocins and are in a combined presence of about 0.1 pg/ml to about 300 g/ml of the wellbore treatment fluid.
- Element 6 wherein the wellbore treatment fluid further comprises a chelating agent selected from the group consisting of: EDTA; CaEDT; CaNa2EDTA; alkyldiamine tetraacetate; EGTA; citrate; and any combination thereof.
- a chelating agent selected from the group consisting of: EDTA; CaEDT; CaNa2EDTA; alkyldiamine tetraacetate; EGTA; citrate; and any combination thereof.
- Element 7 wherein a chelating agent is present in an amount from about 0.1 imM to about 30 imM of the wellbore treatment fluid.
- Element 8 wherein the wellbore treatment fluid further comprises an ionic surfactant selected from the group consisting of: an emulsifier; a fatty acid; a quaternary compound; an anionic surfactant; an amphoteric surfactant; and any combination thereof.
- an ionic surfactant selected from the group consisting of: an emulsifier; a fatty acid; a quaternary compound; an anionic surfactant; an amphoteric surfactant; and any combination thereof.
- Element 9 wherein the wellbore treatment fluid further comprises a nonionic surfactant selected from the group consisting of: a polyoxyalkylphenol; a polyoxyalkylsorbitan; a glyceride; and any combination thereof.
- a nonionic surfactant selected from the group consisting of: a polyoxyalkylphenol; a polyoxyalkylsorbitan; a glyceride; and any combination thereof.
- the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein.
- the particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein.
- no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered, combined, or modified and all such variations are considered within the scope and spirit of the present invention.
- the invention illustratively disclosed herein suitably may be practiced in the absence of any element that is not specifically disclosed herein and/or any optional element disclosed herein.
- compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. All numbers and ranges disclosed above may vary by some amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mining & Mineral Resources (AREA)
- Geology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Environmental & Geological Engineering (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Geochemistry & Mineralogy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Physical Water Treatments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Method comprising providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; combining the wellbore treatment fluid with a a plurality of bacteriocins; placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
Description
METHODS FOR TREATING WELLBORE AN D WELLBORE OPERATION
FLUIDS
BACKGROUN D
[0001 ] The present invention relates to methods for combati ng biological contamination in a wellbore or surrou nding subterranean formation and in wellbore operation flu ids using bacteriocins.
[0002] Oil well stimulation, drilling, recovery, and cleanup operations are often negatively affected by the presence of bacterial contaminants. These contaminants may be present in the liquid treatment fluids or equipment (e.g. , tanks, pumps, structural members, etc.) used for well operations, the subterranean formation itself, or flowback fluids. Bacterial contaminants may cause numerous problems, such as increased corrosion rates and plugging of condu its, filters, and pumps, reservoir sou ring, etc. They may additionally interfere with the desired operational qualities of a particu lar liquid treatment fluid or additive within the treatment fluid . Some bacteria release enzymes that degrade polymers commonly used in well operations and interfere with those operations. For example, degradation of a gel stabi lizer polymer in a treatment flu id could result in a loss in viscosity of the fluid and decrease in ability of the fluid to effectively transport necessary additives. Therefore, it is often desirable to inhibit microbial growth in liquids and substrates (e.g. , metal equipment that comes into contact with the liquids) in well operations.
[0003] A number of methods have been used for reducing or eliminating bacterial contaminants in well operations, such as introducing biocides downhole or using biocides to sterilize flowback flu ids. However, biocides pose significant risk to human health and the environment. Great care is required when handling biocides, necessitating appropriate protective clothing and hazardous disposal practices. Additionally, biocides may have severe and lasting impacts on water sou rces and ecosystems, which may be a particular problem should a well operation fail or the recovered liquids become uncontained . Bacterial contaminants have also been mitigated by irradiation of well operation treatment flu ids and flowback flu ids with ultraviolet light ("UV") . UV irradiation is safer to use than biocides for controlling bacterial contamination . However, UV irradiation requires special UV light sou rces at the
well site and may not effectively kill bacterial contaminants. For example, even if UV irradiation wholly eradicates all bacterial contaminants from well operation fluids or equipment, any contaminants in the wellbore itself still remain and may propagate in the treatment fluids after they are introduced. Moreover, well operation equipment may house bacterial contaminants and introduce those contaminants into already irradiated treatment fluids. Therefore, a method of effectively inhibiting bacterial contaminants in well operations that is safe for human handling and the environment may be beneficial to one of ordinary skill in the art.
SUMMARY OF THE INVENTION
[0004] The present invention relates to methods for combating biological contamination in a wellbore or surrounding subterranean formation and in wellbore operation fluids using bacteriocins.
[0005] In some embodiments, the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; combining the wellbore treatment fluid with a plurality of bacteriocins; placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
[0006] In other embodiments, the present invention provides a method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
[0007] In still other embodiments, the present invention provides a method comprising : providing a portion of a subterranean formation having a
first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; providing particulates having a coating of bacteriocins thereon and a coating of degradable material atop of the coating of bacteriocins; wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a poly(amino acid), a poly(ethylene oxide), a poly(vinylidene chloride), a polyphosphazene, or a combination thereof combining the wellbore treatment fluid with a plurality of bacteriocins; combining the wellbore treatment fluid with the coated particulates; placing the wellbore treatment fluid comprising the coated particulates into a portion of the subterranean formation; releasing the bacteriocins as the degradable coating degrades; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
[0008] The features and advantages of the present invention will be readily apparent to those skilled in the art upon a reading of the description of the preferred embodiments that follows.
DETAILED DESCRIPTION
[0009] The present invention relates to methods for combating biological contamination in a wellbore or surrounding subterranean formation using bacteriocins. The methods of the various embodiments of the present invention may combat biological contamination in a wellbore and flowback fluids, while reducing or eliminating reliance on hazardous biocides or less effective antibacterial treatments.
[0010] In some embodiments, the methods disclosed herein may be used in any type of hydrocarbon recovery operation where disinfecting a treatment fluid or formation face is desired, including, but not limited to, pipeline operations, well servicing operations, upstream exploration and production
operations, downstream refining, processing, storage and transportation applications, and sterilization of flowback fluids.
[0011] As used herein, the term "bacteriocin" refers to a protein or peptide produced by a gram-positive or a gram-negative bacterium that is bactericidal and/or bacteriostatic against organisms related to the producer bacterium, but that does not act against the producer bacterium itself. Bacteriocins, thus, are naturally occurring antibacterial agents. Additionally, bacteriocins are generally produced by non-pathogenic bacteria naturally found in the human body. Therefore, they are prime candidates for medicinal and food-related applications and are safe for human consumption. Indeed, the bacteriocin nisin is listed as Generally Recognized as Safe by the U.S. Food and Drug Administration. The present invention relates to a novel use of bacteriocins in well operations. Not only are bacteriocins useful as an antibacterial agent, they are also generally categorized as food-grade, ensuring that any inadvertent exposure to the bacteriocins would not be hazardous to flora, fauna, or human life.
[0012] The wellbore treatment fluids of the present invention may be any suitable treatment fluids capable of use in a well operation. Suitable treatment fluids may include, but are not limited to, aqueous-based fluids, aqueous-miscible fluids, water-in-oil emulsions, or oil-in-water emulsions. Suitable aqueous-based fluids may include fresh water, saltwater (e.g. , water containing one or more salts dissolved therein), brine (e.g. , saturated salt water), seawater, and any combination thereof. Suitable aqueous-miscible fluids may include, but not be limited to, alcohols, e.g., methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, and t-butanol; glycerins; glycols, e.g., polyglycols, propylene glycol, and ethylene glycol; polyglycol amines; polyols; any derivative thereof; any in combination with salts, e.g., sodium chloride, calcium chloride, calcium bromide, zinc bromide, potassium carbonate, sodium formate, potassium formate, cesium formate, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, ammonium chloride, ammonium bromide, sodium nitrate, potassium nitrate, ammonium nitrate, ammonium sulfate, calcium nitrate, sodium carbonate, and potassium carbonate; any in combination with an aqueous-based fluid; and any combination thereof. Suitable water-in-oil emulsions, also known as invert emulsions, may have an oil-to-water ratio from a lower limit of greater than
about 50 : 50, 55 : 45, 60 :40, 65 : 35, 70 : 30, 75 : 25, or 80 : 20 to an upper limit of less than about 100 : 0, 95 : 5, 90 : 10, 85 : 15, 80 : 20, 75 : 25, 70 : 30, or 65 : 35 by volume in the base fluid, where the amount may range from any lower limit to any upper limit and encompass any subset therebetween. Examples of suitable invert emulsions include those disclosed in U.S. Patent Numbers 5,905,061, 5,977,031, 6,828,279, 7,534,745, 7,645,723, and 7,696, 131, each of which are incorporated in their entirety herein by reference. It should be noted that for water-in-oil and oil-in-water emulsions, any mixture of the above may be used including the water being and/or comprising an aqueous-miscible fluid.
[0013] The wellbore treatment fluids of the present invention may additionally contain an additive or combination of additives including, but not limited to, a salt, a weighting agent, an inert solid, a fluid loss control agent, an emulsifier, a dispersion aid, a corrosion inhibitor, an emulsion thinner, an emulsion thickener, a viscosifying agent, a gelling agent, a surfactant, a particulate, a proppant, a gravel particulate, a lost circulation material, a foaming agent, a gas, a pH control additive, a breaker, a biocide, a crosslinker, a stabilizer, a chelating agent, a scale inhibitor, a gas hydrate inhibitor, a mutual solvent, an oxidizer, a reducer, a friction reducer, a clay stabilizing agent, and any combination thereof.
[0014] The wellbore treatment fluids of the present invention may include drilling fluids, lost circulation fluids, stimulation fluids, sand control fluids, completion fluids, acidizing fluids, scale inhibiting fluids, water-blocking fluids, clay stabilizer fluids, fracturing fluids, frac-packing fluids, gravel packing fluids, wellbore strengthening fluids, acidizing fluids, and sag control fluids. The methods and compositions of the present invention may be used in full-scale fluids or as pills. As used herein, a "pill" is a type of relatively small volume of specially prepared treatment fluid placed or circulated in the wellbore.
[0015] In some embodiments, the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; combining the wellbore treatment fluid with a plurality of bacteriocins; placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation; reducing the first
formation bacterial count to a second formation bacterial cou nt; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial cou nt.
[0016] Because of the mechanism through which bacteriocins work, gram-positive produced bacteriocins generally, but not always, serve as a bactericide to gram-positive bacteria and gram-negative produced bacteriocins generally serve as a bactericide to gram-negative bacteria . Depending on the conditions of the environment, treatment flu id, wellbore conditions, and other well operation parameters, gram-positive bacteriocins, gram-negative bacteriocins, or a combination of both may be used in accordance with the present invention to inhibit bacterial growth .
[0017] Suitable gram-positive bacteriocins include, but are not limited to, acidocin ; actagardine; bovicin ; brochocin; butyrivibriocin ; carnobacteriocin; carnocin ; carnocyclin ; circularin; closticin ; coagulin; curvacin; curvaticin; cytolysin; divercin ; divergicin; du ramycin; enterocin; entianin ; epicidin; epidermin ; epilancin; ericin; gallidermin ; garvicin; gassericin; halodu racin; hiracin ; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin; mutacin; nisin; paenibacillin; pediocin; pep5 lantibiotic; piscicolin; plantaricin; sakacin; salivaricin; smb; staphylococcin ; and any combination thereof. Suitable gram-negative bacteriocins include, but are not limited to, capistru in; colicin; microcin ; pyrocin; serracin; and any combination thereof. Any gram-positive bacteriocin may be combined with any gram-negative bacteriocin to produce the desired effects for a particu lar well operation. In some embodiments, the bacteriocin is present in the wellbore treatment fluid in an amount from about 0.1 g/ml to about 300 g/ml . In preferred embodiments, the bacteriocin is present in the wellbore treatment flu id in an amou nt from about 0. 1 g/ml to about 100 g/ml .
[0018] Bacterial contamination in a well operation may exist in the treatment fluids themselves or the well (e.g., the su bterranean formation) . The treatment fluids containing bacteriocins of the present invention may serve as a bactericide to both because the bacteriocins may be effective against any surface which the treatment fluid contacts.
[0019] The bacteriocins may additionally be used to treat flowback fluids for bacterial contamination . In some embodiments, the present invention
provides a method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
[0020] As used herein, the term "flowback fluid" refers to any fluids that flow from a wellbore following treatment with a wellbore treatment fluid, either in preparation for a subsequent phase of treatment or in preparation for cleanup. Flowback fluids may be any wellbore treatment fluid disclosed herein, including any additive or additives included therein, that flow from the wellbore and to the surface. Additionally, flowback fluids may include produced water or other fluids from the formation, but do not include produced fluids that are obtained during well production (e.g. , hydrocarbons).
[0021] Some well operations take place under conditions having extreme pH or temperature levels. Although any suitable buffering agent that does not interfere with the particular well operation may be used in accordance with the present invention to control pH, particular bacteriocins are able to operate at extreme pH levels. For example, enterocin may be stable at low pH levels (2.0-5.0) and carnobacterium may be stable at high pH levels (8.5-9.5). Like pH, bacteriocins are also able to operate at extreme temperatures. For example, bacteriocins produced by Lactobacillus plantarum are thermotolerant at 100°C for at least 90 minutes and 121°C for at least 20 minutes. (Parada et al., Brazilian Archives of Bio. & Tech. 50 : 521-542 (2007)).
[0022] Bacteriocin activity may be enhanced by the use of a chelating agent and/or a surfactant in combination with the bacteriocin. The use of a chelating agent and/or a surfactant in combination with a bacteriocin can enhance the potency and range of the bacteriocin as a bactericide. Suitable chelating agents include, but are not limited to EDTA, CaEDTA, CaNa2EDTA, alkyldiamine tetraacetates, EGTA, citrate, and any combination thereof. In some embodiments, the chelating agent is present in an amount from about 0.1 imM to about 30 imM of the wellbore treatment fluid or flowback fluid. The surfactants used in the present invention may be ionic or nonionic. Suitable ionic surfactants include, but are not limited to emulsifiers, fatty acids, quaternary compounds, anionic surfactants (e.g. , sodium dodecyl sulphate), amphoteric
surfactants {e.g. , cocamidopropyl betaine), and any combination thereof. Suitable nonionic surfactants include, but are not limited to, polyoxyalkylphenols {e.g. , Triton X- 100), polyoxyalkylsorbitans {e.g. , Tweens), glycerides {e.g. , monolaurin and dioleates), and any combination thereof. In some embodiments, one or more surfactants are present in the wellbore treatment fluids and/or flowback fluids of the present invention in an amount from about 0.01% to about 5.0%. In other embodiments, the surfactants are present from about 0.1% to about 1.0% of the wellbore treatment fluids and/or flowback fluids.
[0023] In some embodiments, the present invention provides a method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid; providing particulates having a coating of bacteriocins thereon and a coating of degradable material atop of the coating of bacteriocins; wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a poly(amino acid), a poly(ethylene oxide), a poly(vinylidene chloride), a polyphosphazene, or a combination thereof combining the wellbore treatment fluid with a plurality of bacteriocins; combining the wellbore treatment fluid with the coated particulates; placing the wellbore treatment fluid comprising the coated particulates into a portion of the subterranean formation; releasing the bacteriocins as the degradable coating degrades; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
[0024] In such embodiments, the bacteriocins may be advantageously delivered to a desired location in a subterranean formation along with particulates (such as proppant or gravel). In these particulate embodiments, it may be desirable to coat at least a portion of the particulates with bacteriocins absorbed thereon with a degradable coating that will degrade over time and thus release the bacteriocins over time. Suitable degradable coatings include
degradable polymers, waxes, and latexes. Degradable polymers suitable for use in the present invention are capable of undergoing an irreversible degradation down hole. The term "irreversible" as used herein means that the degradable material, once degraded down hole, should not recrystallize or reconsolidate while down hole, e.g. , the degradable material should degrade in situ but should not recrystallize or reconsolidate in situ . The terms "degradation" or "degradable" refer to both the two relatively extreme cases of hydrolytic degradation that the degradable material may undergo, i.e. , heterogeneous (or bulk erosion) and homogeneous (or surface erosion), and any stage of degradation in between these two. This degradation can be a result of a physical change, chemical process, or a thermal process. Suitable examples of degradable polymers that may be used in accordance with the present invention include, but are not limited to, polysaccharides; cellulose; chitins; chitosans; proteins; aliphatic polyesters; poly(lactides); poly(glycolides); poly(s- caprolactones); poly(hydroxybutyrates); poly(anhydrides); aliphatic polycarbonates; poly(orthoesters); poly(amino acids); poly(ethylene oxides); poly(vindylidene chloride); and polyphosphazenes. Of these suitable polymers, aliphatic polyesters and polyanhydrides may be preferred. Additional detail regarding acceptable degradable polymers can be found in U.S. Patent No. 7,044,220, the entire disclosure of which is hereby incorporated by reference.
[0025] In still other embodiments, the bacteriocins may be coated directly onto a solid fluid loss control agent used in a subterranean treatment fluid. By placing the bacteriocins onto fluid loss control particles, the methods of the present invention are able to place the bacteriocins directly at, for example, a fracture face, thus potentially stopping the influx of harmful bacteria before they reach producing zones. Any solid fluid loss control agent known in the art may be used to deliver the bacteriocins in these embodiments of the present invention. Some common fluid loss control agents include silica, mica, calcite, aliphatic polyester, polylactic acid, a poly(lactide), a poly(orthoester), a surfactant- based fluid loss control agent (such as those described in United States Patent No. 7,413,013, the entire disclosure of which is hereby incorporated by reference), carboxymethylcellulose, carboxyethylcellulose, and polyacrylates.
[0026] One of skill in the art will recognize that where a coated particulate embodiment of the present invention is used, a chelating agent
and/or a surfactant may be combined with the bacteriocin before it is coated onto the particulate.
[0027] Embodiments disclosed herein include:
[0028] A. A method comprising : providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation; providing a weiibore treatment fluid having a first weiibore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the weiibore treatment fluid; combining the weiibore treatment fluid with a plurality of bacteriocins; placing the weiibore treatment fluid into a weiibore in the portion of the subterranean formation; reducing the first formation bacterial count to a second formation bacterial count; and reducing the first weiibore treatment fluid bacterial count to a second weiibore treatment fluid bacterial count.
[0029] B. A method comprising : providing a portion of a subterranean formation; providing a flowback fluid that has previously been present in a portion of a subterranean formation; wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria; combining the flowback fluid with a plurality of bacteriocins; and reducing the first bacterial count to a second bacterial count.
[0030] Each of embodiments A and B may have one or more of the following additional elements in any combination :
[0031] Element 1 : wherein the bacteriocins are coated onto a plurality of particulates and wherein a coating of degradable material is placed atop of the coating of bacteriocins, wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a poly(amino acid), a poly(ethylene oxide), a poly(vinylidene chloride), a polyphosphazene, or a combination thereof; and wherein the degradable coating degrades after the step of placing the weiibore treatment fluid into a weiibore.
[0032] Element 2 : wherein the bacteriocins are gram-positive bacteria produced bacteriocins, gram-negative bacteria produced bacteriocins, or a combination thereof.
[0033] Element 3 : wherein the bacteriocins are gram-positive bacteria produced bacteriocins selected from the group consisting of: acidocin;
actagardine; bovicin; brochocin; butyrivibriocin; carnobacteriocin; carnocin; carnocyclin; circularin; closticin; coagulin; curvacin; curvaticin; cytolysin; divercin; divergicin; duramycin; enterocin; entianin; epicidin; epidermin; epilancin; ericin; gallidermin; garvicin; gassericin; haloduracin; hiracin; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin; mutacin; nisin; paenibacillin; pediocin; pep5 lantibiotic; piscicolin; plantaricin; sakacin; salivaricin; smb; staphylococcin; and any combination thereof.
[0034] Element 4 : wherein the bacteriocins are gram-negative bacteria produced bacteriocins selected from the group consisting of: capistruin; colicin; microcin; pyrocin; serracin; and any combination thereof.
[0035] Element 5 : wherein the bacteriocins are gram-positive bacteria produced bacteriocins and gram-negative bacteria produced bacteriocins and are in a combined presence of about 0.1 pg/ml to about 300 g/ml of the wellbore treatment fluid.
[0036] Element 6 : wherein the wellbore treatment fluid further comprises a chelating agent selected from the group consisting of: EDTA; CaEDT; CaNa2EDTA; alkyldiamine tetraacetate; EGTA; citrate; and any combination thereof.
[0037] Element 7: wherein a chelating agent is present in an amount from about 0.1 imM to about 30 imM of the wellbore treatment fluid.
[0038] Element 8 : wherein the wellbore treatment fluid further comprises an ionic surfactant selected from the group consisting of: an emulsifier; a fatty acid; a quaternary compound; an anionic surfactant; an amphoteric surfactant; and any combination thereof.
[0039] Element 9 : wherein the wellbore treatment fluid further comprises a nonionic surfactant selected from the group consisting of: a polyoxyalkylphenol; a polyoxyalkylsorbitan; a glyceride; and any combination thereof.
[0040] Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design
herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered, combined, or modified and all such variations are considered within the scope and spirit of the present invention. The invention illustratively disclosed herein suitably may be practiced in the absence of any element that is not specifically disclosed herein and/or any optional element disclosed herein. While compositions and methods are described in terms of "comprising," "containing," or "including" various components or steps, the compositions and methods can also "consist essentially of" or "consist of" the various components and steps. All numbers and ranges disclosed above may vary by some amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, "from about a to about b," or, equivalently, "from approximately a to b," or, equivalently, "from approximately a-b") disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee. Moreover, the indefinite articles "a" or "an," as used in the claims, are defined herein to mean one or more than one of the element that it introduces. If there is any conflict in the usages of a word or term in this specification and one or more patent or other documents that may be incorporated herein by reference, the definitions that are consistent with this specification should be adopted.
Claims
1. A method comprising :
providing a portion of a subterranean formation having a first formation bacterial count as a result of the presence of a plurality of bacteria in the formation;
providing a wellbore treatment fluid having a first wellbore treatment fluid bacterial count as a result of the presence of a plurality of bacteria in the wellbore treatment fluid;
combining the wellbore treatment fluid with a plurality of bacteriocins;
placing the wellbore treatment fluid into a wellbore in the portion of the subterranean formation;
reducing the first formation bacterial count to a second formation bacterial count; and
reducing the first wellbore treatment fluid bacterial count to a second wellbore treatment fluid bacterial count.
2. The method of claim 1, wherein the bacteriocins are coated onto a plurality of particulates and wherein a coating of degradable material is placed atop of the coating of bacteriocins,
wherein the degradable coating is a polysaccharide, a cellulose, a chitin, a chitosan, a protein, an aliphatic polyester, a poly(lactide), a poly(glycolide), a poly(s-caprolactone), a poly(hydrobutyrate), a poly(anhydride), an aliphatic polycarbonate, a poly(orthoester), a poly(amino acid), a poly(ethylene oxide), a poly(vinylidene chloride), a polyphosphazene, or a combination thereof; and
wherein the degradable coating degrades after the step of placing the wellbore treatment fluid into a wellbore.
3. The method of claim 1, wherein the bacteriocins are gram-positive bacteria produced bacteriocins, gram-negative bacteria produced bacteriocins, or a combination thereof.
4. The method of claim 1, wherein the bacteriocins are gram-positive bacteria produced bacteriocins selected from the group consisting of: acidocin; actagardine; bovicin; brochocin; butyrivibriocin; carnobacteriocin; carnocin; carnocyclin; circularin; closticin; coagulin; curvacin; curvaticin; cytolysin;
divercin; divergicin; duramycin; enterocin; entianin; epicidin; epidermin; epilancin; ericin; gallidermin; garvicin; gassericin; haloduracin; hiracin; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin; mutacin; nisin; paenibacillin; pediocin; pep5 lantibiotic; piscicolin; plantaricin; sakacin; salivaricin; smb; staphylococcin; and any combination thereof.
5. The method of claim 1, wherein the bacteriocins are gram-negative bacteria produced bacteriocins selected from the group consisting of: capistruin; colicin; microcin; pyrocin; serracin; and any combination thereof.
6. The method of claim 1, wherein the bacteriocins are gram-positive bacteria produced bacteriocins and gram-negative bacteria produced bacteriocins and are in a combined presence of about 0.1 g/ml to about 300 g/ml of the wellbore treatment fluid.
7. The method of claim 1, wherein the wellbore treatment fluid further comprises a chelating agent selected from the group consisting of: EDTA; CaEDT; CaNa2EDTA; alkyldiamine tetraacetate; EGTA; citrate; and any combination thereof.
8. The method of claim 6, wherein the chelating agent is present in an amount from about 0.1 imM to about 30 imM of the wellbore treatment fluid.
9. The method of claim 1, wherein the wellbore treatment fluid further comprises an ionic surfactant selected from the group consisting of: an emulsifier; a fatty acid; a quaternary compound; an anionic surfactant; an amphoteric surfactant; and any combination thereof.
10. The method of claim 1, wherein the wellbore treatment fluid further comprises a nonionic surfactant selected from the group consisting of: a polyoxyalkylphenol; a polyoxyalkylsorbitan; a glyceride; and any combination thereof.
11. A method comprising :
providing a portion of a subterranean formation;
providing a flowback fluid that has previously been present in a portion of a subterranean formation;
wherein the flowback fluid has a first bacterial count as a result of the presence of a plurality of bacteria;
combining the flowback fluid with a plurality of bacteriocins; and
reducing the first bacterial count to a second bacterial count.
12. The method of claim 11, wherein the bacteriocins are gram-positive bacteria produced bacteriocins, gram-negative bacteria produced bacteriocins, or a combination thereof.
13. The method of claim 11, wherein the bacteriocins are gram-positive bacteria produced bacteriocins selected from the group consisting of: acidocin; actagardine; bovicin; brochocin; butyrivibriocin; carnobacteriocin; carnocin; carnocyclin; circularin; closticin; coagulin; curvacin; curvaticin; cytolysin; divercin; divergicin; duramycin; enterocin; entianin; epicidin; epidermin; epilancin; ericin; gallidermin; garvicin; gassericin; haloduracin; hiracin; hominicin; ipomicin; lactacin; lactoccin; lactocyclin; lantibiotic; leucocin; lichenicidin; listeriocin; lysostaphin; mesentericin; microbisporicin; mundticin; mutacin; nisin; paenibacillin; pediocin; pep5 lantibiotic; piscicolin; plantaricin; sakacin; salivaricin; smb; staphylococcin; and any combination thereof.
14. The method of claim 11, wherein the bacteriocins are gram- negative bacteria produced bacteriocins selected from the group consisting of: capistruin; colicin; microcin; pyrocin; serracin; and any combination thereof.
15. The method of claim 11, wherein the flowback fluid further comprises a chelating agent selected from the group consisting of: EDTA; CaEDTA; CaNa2EDTA; alkyldiamine tetraacetate; EGTA; citrate; and any combination thereof.
16. The method of claim 11, wherein the flowback fluid further comprises an ionic surfactant selected from the group consisting of: an emulsifier; a fatty acid; a quaternary compound; an anionic surfactant; an amphoteric surfactant; and any combination thereof.
17. The method of claim 11, wherein the flowback fluid further comprises a nonionic surfactant selected from the group consisting of: a polyoxyalkylphenol; a polyoxyalkylsorbitan; a glyceride; and any combination thereof.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2015003020A MX2015003020A (en) | 2012-09-28 | 2013-09-26 | Methods for treating wellbore and wellbore operation fluids. |
| AU2013323554A AU2013323554B2 (en) | 2012-09-28 | 2013-09-26 | Methods for treating wellbore and wellbore operation fluids |
| EP13841298.6A EP2900784A4 (en) | 2012-09-28 | 2013-09-26 | Methods for treating wellbore and wellbore operation fluids |
| CA2882949A CA2882949A1 (en) | 2012-09-28 | 2013-09-26 | Well treatment fluid comprising bacteriocins and method of using same for combating biological contamination |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/629,664 US20140090833A1 (en) | 2012-09-28 | 2012-09-28 | Methods for Treating Wellbore and Wellbore Operation Fluids |
| US13/629,664 | 2012-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014052519A1 true WO2014052519A1 (en) | 2014-04-03 |
Family
ID=50384123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2013/061804 WO2014052519A1 (en) | 2012-09-28 | 2013-09-26 | Methods for treating wellbore and wellbore operation fluids |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20140090833A1 (en) |
| EP (1) | EP2900784A4 (en) |
| CA (1) | CA2882949A1 (en) |
| MX (1) | MX2015003020A (en) |
| WO (1) | WO2014052519A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017027002A1 (en) | 2015-08-10 | 2017-02-16 | Baker Hughes Incorporated | Proteins for removing sulfurous compounds and/or acidic compounds in downhole fluids |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9200251B1 (en) | 2011-03-31 | 2015-12-01 | David Gordon Bermudes | Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith |
| WO2017048320A1 (en) * | 2015-09-14 | 2017-03-23 | M-I L.L.C. | Methods of microbial measuring and control |
| WO2019014061A1 (en) | 2017-07-12 | 2019-01-17 | Dow Global Technologies, Llc | Compositions and methods for remediation of sulfate reducing prokaryotes |
| US20230272264A1 (en) * | 2021-12-28 | 2023-08-31 | Dalian University Of Technology | Environmentally friendly natural gas hydrate inhibitor and application |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020020527A1 (en) * | 2000-07-21 | 2002-02-21 | Lars Kilaas | Combined liner and matrix system |
| US20090062156A1 (en) * | 2007-08-31 | 2009-03-05 | Halliburton Energy Services, Inc. | Methods of treating a subterranean formation including a biocidal treatment |
| US20100218950A1 (en) * | 2006-08-02 | 2010-09-02 | Kemira Chemicals, Inc. | Biocide for well stimulation and treatment fluids |
| US20110311645A1 (en) * | 2010-06-16 | 2011-12-22 | Diaz Raul O | Microbiological control in oil and gas operations |
| US20120073821A1 (en) * | 2010-09-28 | 2012-03-29 | Jeremy Holtsclaw | Methods for Reducing Biological Load in Subterranean Formations |
| US20120181027A1 (en) * | 2007-05-22 | 2012-07-19 | Halliburton Energy Services, Inc. | Viscosified Fluids for Remediating Subterranean Damage |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507212A (en) * | 1982-11-15 | 1985-03-26 | The Standard Oil Company | Nitrile compounds as oil field biocides |
| US4980163A (en) * | 1989-03-01 | 1990-12-25 | Public Health Research Institute Of The City Of New York | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
| US6258859B1 (en) * | 1997-06-10 | 2001-07-10 | Rhodia, Inc. | Viscoelastic surfactant fluids and related methods of use |
| US7413013B2 (en) * | 2006-09-29 | 2008-08-19 | Halliburton Energy Services, Inc. | Surfactant-based fluid loss control agents for surfactant gels and associated fluids and methods |
| US7910524B2 (en) * | 2007-02-08 | 2011-03-22 | Halliburton Energy Services, Inc. | Treatment fluids comprising diutan and associated methods |
| US20080287323A1 (en) * | 2007-05-16 | 2008-11-20 | Leiming Li | Treatment and Reuse of Oilfield Produced Water |
| WO2012145185A1 (en) * | 2011-04-09 | 2012-10-26 | Vh Biotechnology, Inc. | Bacteriocins as biocides for industrial uses |
-
2012
- 2012-09-28 US US13/629,664 patent/US20140090833A1/en not_active Abandoned
-
2013
- 2013-09-26 EP EP13841298.6A patent/EP2900784A4/en not_active Withdrawn
- 2013-09-26 CA CA2882949A patent/CA2882949A1/en not_active Abandoned
- 2013-09-26 WO PCT/US2013/061804 patent/WO2014052519A1/en active Application Filing
- 2013-09-26 MX MX2015003020A patent/MX2015003020A/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020020527A1 (en) * | 2000-07-21 | 2002-02-21 | Lars Kilaas | Combined liner and matrix system |
| US20100218950A1 (en) * | 2006-08-02 | 2010-09-02 | Kemira Chemicals, Inc. | Biocide for well stimulation and treatment fluids |
| US20120181027A1 (en) * | 2007-05-22 | 2012-07-19 | Halliburton Energy Services, Inc. | Viscosified Fluids for Remediating Subterranean Damage |
| US20090062156A1 (en) * | 2007-08-31 | 2009-03-05 | Halliburton Energy Services, Inc. | Methods of treating a subterranean formation including a biocidal treatment |
| US20110311645A1 (en) * | 2010-06-16 | 2011-12-22 | Diaz Raul O | Microbiological control in oil and gas operations |
| US20120073821A1 (en) * | 2010-09-28 | 2012-03-29 | Jeremy Holtsclaw | Methods for Reducing Biological Load in Subterranean Formations |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP2900784A4 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017027002A1 (en) | 2015-08-10 | 2017-02-16 | Baker Hughes Incorporated | Proteins for removing sulfurous compounds and/or acidic compounds in downhole fluids |
| CN107995919A (en) * | 2015-08-10 | 2018-05-04 | 通用电气(Ge)贝克休斯有限责任公司 | For removing the protein of sulfur-containing compound and/or acid compound in downhole fluid |
| CN107995919B (en) * | 2015-08-10 | 2021-03-02 | 通用电气(Ge)贝克休斯有限责任公司 | Proteins for removal of sulfur-containing and/or acidic compounds in downhole fluids |
| US10947433B2 (en) | 2015-08-10 | 2021-03-16 | Baker Hughes Holdings Llc | Proteins for removing sulfurous compounds and/or acidic compounds in downhole fluids |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2900784A1 (en) | 2015-08-05 |
| CA2882949A1 (en) | 2014-04-03 |
| EP2900784A4 (en) | 2016-06-01 |
| US20140090833A1 (en) | 2014-04-03 |
| AU2013323554A1 (en) | 2015-03-19 |
| MX2015003020A (en) | 2015-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014052519A1 (en) | Methods for treating wellbore and wellbore operation fluids | |
| EP2652073B1 (en) | Process and fluid to improve the permeability of sandstone formations using a chelating agent | |
| CN101679846B (en) | Procedures and compositions for reservoir protection | |
| US9587171B2 (en) | Ammonium salts of chelating agents and their use in oil and gas field applications | |
| US8550161B2 (en) | Shear-activated viscoelastic surfactant fluid and method | |
| CA2946586C (en) | Compositions for use in corrosion protection | |
| US20090062156A1 (en) | Methods of treating a subterranean formation including a biocidal treatment | |
| MX2013012402A (en) | Treatment fluids containing biodegradable chelating agents and methods for use thereof. | |
| US8772206B2 (en) | Treatment fluids made of halogenisocyanuric acid and its salts for operations in a well | |
| WO2015001498A1 (en) | Visco elastic surfactant crosslinked with divalent ions | |
| CA2908746A1 (en) | Biocidal systems and methods of use | |
| EP2800793B1 (en) | Method of using a biocidal system | |
| WO2016196680A1 (en) | Biofilm control and frack fluid production using bacillus subtilis activated with gfak | |
| CA2911194A1 (en) | Process to treat subterranean formations including a soaking step and using a chelating agent | |
| EP2700313B1 (en) | Biocidal compositions comprising glutaraldehyde and tris(hydroxymethyl)nitromethane and methods of use | |
| AU2013323554B2 (en) | Methods for treating wellbore and wellbore operation fluids | |
| US20180118998A1 (en) | Controlled-Release Chemical Particulate Composition for Well Treatment | |
| EP3134355B1 (en) | Hydrotesting and mothballing composition and method of using combination products for multifunctional water treatment | |
| EP3174950B1 (en) | Microbiocides and uses thereof | |
| US10611953B2 (en) | Controlled release of well treatment agents into oil wells | |
| US20120181022A1 (en) | Vda/acid system for matrix acid stimulation | |
| WO2023283727A1 (en) | Use of percitric acid in oil- and gas-field operations | |
| WO2014147485A2 (en) | Biocide treatment method and system | |
| CA3077382A1 (en) | Treatment of circulating water systems including well treatment fluids for oil and gas applications | |
| Mukhopadhyay et al. | A New Technology That Delivers Long-Term Chemical Treatment During Well Stimulation: Organic Deposits, Inorganic Scales, and Corrosion Control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13841298 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2882949 Country of ref document: CA |
|
| REEP | Request for entry into the european phase |
Ref document number: 2013841298 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2013841298 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/003020 Country of ref document: MX |
|
| ENP | Entry into the national phase |
Ref document number: 2013323554 Country of ref document: AU Date of ref document: 20130926 Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |